Propanc Biopharma Q3 EPS $(0.28) Up From $(12.50) YoY

Benzinga Newsdesk www.benzinga.com Negative 51.3%

Neg 51.3% Neu 0% Pos 0%

Propanc Biopharma (NASDAQ:PPCB) reported quarterly losses of $(0.28) per share. This is a 97.76 percent increase over losses of $(12.50) per share from the same period last year.